Impact of Minimal Residual Negativity using Next Generation Flow Cytometry on Outcomes in Light Chain Amyloidosis

We evaluated bone marrow minimal residual disease (MRD) negativity in 44 patients with light chain (AL) amyloidosis using next generation flow cytometry (sensitivity ≥ 1× 10(−5); median events analyzed: 8.7 million, range: 4.8 to 9.7 million). All patients underwent MRD testing in two years from sta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Hematol
Egile Nagusiak: Sidana, Surbhi, Muchtar, Eli, Sidiqi, M.Hasib, Jevremovic, Dragan, Dispenzieri, Angela, Gonsalves, Wilson, Buadi, Francis, Lacy, Martha Q., Hayman, Suzanne R., Kourelis, Taxiarchis, Kapoor, Prashant, Go, Ronald S., Warsame, Rahma, Leung, Nelson, Rajkumar, S.Vincent, Kyle, Robert A., Gertz, Morie A., Kumar, Shaji K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019396/
https://ncbi.nlm.nih.gov/pubmed/32010993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25746
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak